Fast and sensitive new HPLC-UV method for determination of omeprazole and major related substances in pharmaceutical formulation

Journal of Liquid Chromatography and Related Technologies

Volumn 33, Issue 18, 2010, Pages 1666-1678

  Flor, Sabrina ^a   Tripodi, Valeria ^a,b   Scioscia, Silvia ^a   Revello, Lucas ^a   Lucangioli, Silvia ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Consejo Nacional de Investigaciones Científicas y Tecnológicas CONICET ^*  (Argentina)

Author keywords

fast and microbore column; omeprazole; pharmaceutical formulation; related substances

Indexed keywords

CHROMATOGRAPHIC CONDITIONS; FAST AND MICROBORE COLUMN; HPLC METHOD; HPLC-UV; HYBRID PARTICLES; INJECTION VOLUME; MOBILE PHASE; OMEPRAZOLE; PHARMACEUTICAL FORMULATION; PHOSPHATE BUFFERS; REDUCED LENGTH; RELATED SUBSTANCES; STABILITY STUDY; UV DETECTION;

CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL;

DRUG PRODUCTS;

BUFFER; METHANOL; OMEPRAZOLE; OMEPRAZOLE SULFONE; PHOSPHATE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG PURITY; DRUG STABILITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYBRID; PH; QUALITY CONTROL; QUANTITATIVE ANALYSIS; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 78649514390     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2010.519232     Document Type: Article

References (17)

1. Shi, S.; Klotz, U. Proton Pump Inhibitors: An Update of Their Clinical Use and Pharmacokinetics. Eur. J. Clin. Pharmacol. 2008, 64, 935-951.
2. Mathew, M.; Das Gupta, V.; Bailey, R. Stability of Omeprazole Solutions at Various pH Values as Determined by High-Performance Liquid Chromatography. Drug Develop. Ind. Pharm. 1995, 21 (8), 965-971.
3. Wahbi, A.; Abdel-Razak, O.; Gazy, A.; Mahgoub, H.; Moneeb, M. Spectrophotometric Determination of Omeprazole, Lansoprazole and Pantoprazole in Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2002, 30 (4), 1133-1142.
4. Pinzauti, S.; Gratteri, P.; Furlanetto, S.; Mura, P.; Dreassi, E.; Phan-Tan-Luu, R. Experimental Design in the Development of Voltammetric Method for the Assay of Omeprazole. J. Pharm. Biomed. Anal. 1996, 14 (8-10), 881-889.
5. Agbaba, D.; Novovic, D.; Karljikovié-Rajie, K.; Marinkovié, V. Densitometric Determination of Omeprazole, Pantoprazole, and their impurities in Pharmaceuticals. J. Planar Chromatogr. Mod. TLC. 2004, 17, 169-172.
6. Pérez-Ruiz, T.; Martínez-Lozano, C.; Sanz, A.; Bravo, E.; Galera, R. Determination of Omeprazole, Hydroxyomeprazole and Omeprazole Sulfone Using Automated Solid Phase Extraction and Micellar Electrokinetic Capillary Chromatography. J. Pharm. Biomed. Anal. 2006, 42 (1), 100-106.
7. Yuen, K.; Choy, W.; Tan, H.; Wong, J.; Yap, S. Improved High Performance Liquid Chromatographic Analysis of Omeprazole in Human Plasma. J. Pharm. Biomed. Anal. 2001, 24 (4), 715-719.
8. Espinosa Bosch, M.; Ruiz Sánchez, A. J.; Sánchez Rojas, F.; Bosch Ojeda, C. Analytical Methodologies for the Determination of Omeprazole: An Overview. J. Pharm. Biomed. Anal. 2007, 44, 831-844.
9. Sluggett, G. W.; Stong, J. D.; Adams, J. H.; Zhao, Z. Omeprazole Determination using HPLC with Coulometric Detection. J. Pharm. Biomed. Anal. 2001, 25, 357-361.
10. Hofmann, U.; Schwab, M.; Treiber, G.; Klotz, U. Sensitive Quantification of Omeprazole and its Metabolites in Human Plasma by Liquid Chromatography-Mass Spectrometry. J. Chromatogr. B 2006, 831 (1-2), 85-90.
11. United States Pharmacopeia 32 Revision; United States Pharmacopeial Convention: Rockville, MD, USA, 2009; p. 3132.
12. Rozing, G.; Nägele, E.; Hörth, P.; Vollmer, M.; Moritz, R.; Glatz, B.; Gratzfeld-Hüsgen, A. Instrumentation for Advanced Microseparations in Pharmaceutical Analysis and Proteomics. J. Biochem. Biophys. Methods. 2004, 60, 233-263.
13. Tripodi, V.; Flor, S.; Contin, M.; Lucangioli, S. Simple, Highly Sensitive Micro HPLC Method for the Determination of Coenzyma Q10 and its Major Related Substances. J. Liq. Chromatogr.&Rel. Technol. 2009, 32 (6), 860-873.
14. Food and Drug Administration. "Acetonitrile Shortages: Recommendations for Reporting Changes in Analytical Procedures." www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM171776. pdf. September 14, 2009.
15. United States Pharmacopeia 32 Revision; United States Pharmacopeial Convention: Rockville, MD, USA, 2009, p. 227.
16. Guidance Q2 (R1), Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization. Final version 2005, http://www.ich.org
17. Vander Heyden, Y.; Nijhuis, A.; Smeyers-Verbeke, J.; Vandeginste, B.; Massart, D. Guidance for robustness/ruggedness test in method validation. J. Pharm. Biomed. Anal. 2001, 24, 723-753.